Intraocular Pressure and Anterior Segment Morphometry Changes after Uneventful Phacoemulsification in Type 2 Diabetic and Nondiabetic Patients

Table 5

Review of studies assessing the IOP reduction and AS changes after phacoemulsification by Scheimpflug imaging.

Study (year)

Patients (eyes)

Glaucoma

Age (y)

Female (n)

Follow-up

IOP pre-op (mmHg)

IOP Δ (mmHg)

ACD pre-op (mm)

ACD Δ (mm)

ACV pre-op (mm^3)

ACV Δ (mm^3)

ACA pre-op (°)

ACA Δ (°)

Hayashi et al. [2] (2000)^a

77 (77)

ACG

74 ± 8

56 (73%)

12 mo

21.4 ± 3.9

−6.1 ± 3.9

1.9 ± 0.3

+2.1 ± 0.4

n.r.

n.r.

19 ± 4

+18 ± 5

73 (73)

OAG

74 ± 7

39 (53%)

20.5 ± 5.4

−4.4 ± 4.3

2.8 ± 0.4

+1.5 ± 0.4

28 ± 5

+10 ± 7

74 (74)

No

72 ± 11

40 (54%)

17.3 ± 3.3

−1.0 ± 4.1

2.9 ± 0.4

+1.4 ± 0.6

27 ± 6

+11 ± 8

Uçakhan et al. [28] (2009)^b

44 (44)

No

66 ± 8

n.r.

3 mo

15.8 ± 3.7

−2.6 ± n.r.

3.0 ± 0.8

+0.9 ± n.r.

165 ± 50

+36 ± n.r.

36 ± 10

+6 ± n.r.

Doganay et al. [29] (2010)^b

34 (42)

No

65 ± 8

8 (24%)

6 mo

14.6 ± 2.5

−2.8 ± n.r.

2.8 ± 0.4

+1.9 ± n.r.

145 ± 44

+46 ± n.r.

33 ± 6

+10 ± n.r.

Dooley et al. [8] (2010)^b

101 (101)

No

69 ± 11

62 (62%)

6 weeks

14.8 ± 3.1

−2.5 ± 3.2

2.7 ± 0.4

+1.1 ± 0.5

142 ± 49

+54 ± 27

30 ± 6

+13 ± 7

Mota et al. [9] (2011)^c

30 (31)

No

73 ± 8

18 (58%)

1 mo

20.5 ± 4.4^e

−3.9 ± 5.6

2.8 ± 0.5

+1.5 ± 0.7

n.r.

n.r.

32 ± 6

+13 ± 6

Takmaz et al. [30] (2012)^d

54 (56)

No

66 ± 10

30 (56%)

1 mo

14.6 ± 3.5

−4.2 ± n.r.

2.7 ± 0.4

+0.8 ± n.r.

144 ± 49

+49 ± n.r.

42 ± 8

+11 ± n.r.

Şimşek et al. [31] (2016)^d

132 (132)

No

64 ± 13

46 (35%)

3 mo

14.7 ± 2.6

−2.4 ± n.r.

2.8 ± 0.4

+0.7 ± n.r.

125 ± 26

+38 ± n.r.

42 ± 7

+9 ± n.r.

Statistically significant difference at . AS, anterior segment; CCT, central corneal thickness; n.r., not reported; SD, standard deviation; SE, standard error; US, ultrasound pachymetry; y, years; mmHg, millimeters of mercury. ^aAS evaluation with EAS-1000 (Scheimpflug videophotography system); ^bAS evaluation with Pentacam CES; ^cAS evaluation with Pentacam HR; ^dAS evaluation with Sirius; ^eIOP was measured with ocular response analyzer.